Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS
BioSpace - 2024-04-06T09:20:06.868Z

Seeking a potential slice of the challenging KRAS market, Merck has launched a Phase III trial of its oral G12C inhibitor MK-1084, in combination with Keytruda, in pursuit of Amgen and Bristol Myers Squibb.

In related news

Mystery 'glove launch presentation' is teased ahead of UFC 300, with fans hoping a new design will FINALLY be announced to help stop eye pokes
UFC gloves have come under fire from fans and fighters due to eye pokes. It has been argued that design should be changed to more natural fist position. It remains to be seen if new announcement is for sponsorship or fresh design
- Related Articles
- In News
- From Daily Mail
- 2024-04-09T15:26:44.000Z
Studying Challenges to Cozumel's Coral Reefs
TNC and Nat Geo Extern Sophie Dellinger examines the impacts of poor water quality on the coral reefs of Cozumel.
- Related Articles
- In News
- From Cool Green Science
- 2024-04-09T23:56:57.000Z
Dinosaur study challenges Bergmann's rule
When you throw dinosaurs into the mix, sometimes you find that a rule simply isn't.
- Related Articles
- In News
- From Phys.org
- 2024-04-06T10:19:22.000Z

In related news

Mystery 'glove launch presentation' is teased ahead of UFC 300, with fans hoping a new design will FINALLY be announced to help stop eye pokes

Studying Challenges to Cozumel's Coral Reefs

Dinosaur study challenges Bergmann's rule